Masimo has had a lot of distractions in the past couple years, between its high-profile patent battle against Apple plus tensions between CEO Joe Kiani and the board.
In March, the company revealed plans to separate its controversial consumer business. The same week, Politan nominated two more candidates to Masimo’s board.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,